Toxicities Associated with Continuing Disease-Modifying Antirheumatic Drugs for Collagen Vascular Diseases During Head and Neck Intensity-Modulated Radiotherapy: A Single-Institution Experience
{{output}}
ImportanceLimited evidence exists to guide the safe use of radiotherapy (RT) and concurrent disease-modifying antirheumatic drugs (DMARDs) in patients with collagen vascular disease (CVD).ObjectiveTo describe toxicity outcomes in patients with CVD receiving in... ...
